Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services Gethin L. GriffithRhiannon Tudor EdwardsPaul Bennett OriginalPaper 27 September 2008 Pages: 265 - 275
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting Debra MorganHeather SylvesterSusan Miesfeldt OriginalPaper 04 April 2009 Pages: 277 - 287
Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing Makia J. MarafieSadiqa Al-AwadiFahd Al-Mulla OriginalPaper 08 August 2009 Pages: 289 - 298
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer Marijana LijovicSusan R. DavisRobin J. Bell OriginalPaper 17 February 2009 Pages: 299 - 305
Genetic polymorphism in ornithine decarboxylase and risk of breast cancer Iain BrownSusan HallidayAndrew C. Schofield OriginalPaper 19 February 2009 Pages: 307 - 311
Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis Michael D. WalshDaniel D. BuchananJoanne P. Young OriginalPaper 25 February 2009 Pages: 313 - 323
Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact Karin M. LandsbergenJudith B. PrinsNicoline Hoogerbrugge OriginalPaper Open access 28 March 2009 Pages: 325 - 337
Methylation not a frequent “second hit” in tumors with germline BRCA mutations Amy M. DworkinAndrew D. SpearmanAmanda Ewart Toland OriginalPaper 02 April 2009 Pages: 339 - 346
PALB2 sequence variants in young South African breast cancer patients Michelle SluiterSamantha MewElizabeth J. van Rensburg OriginalPaper 31 March 2009 Pages: 347 - 353
CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia Eswary ThirthagiriLeng San CheongSoo-Hwang Teo BriefCommunication 28 April 2009 Pages: 355 - 358
First case report of Muir–Torre syndrome associated with non-small cell lung cancer L. NolanD. EcclesC. Ottensmeier OriginalPaper 16 May 2009 Pages: 359 - 362
Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals Wendy McKinnonKimberly C. BanksMarie Wood OriginalPaper 24 May 2009 Pages: 363 - 369
Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes Valérie ChaudruM. T. LoB. Bressac-de Paillerets OriginalPaper 31 May 2009 Pages: 371 - 377
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation Caterina MianSusi BarolloGiuseppe Opocher BriefCommunication 28 May 2009 Pages: 379 - 382
TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset Carla PintoIsabel VeigaManuel R. Teixeira OriginalPaper 26 May 2009 Pages: 383 - 390
Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome Lotte H. M. GerritzenNicoline HoogerbruggeJoanne A. de Hullu OriginalPaper Open access 06 June 2009 Pages: 391 - 397
The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women Tal Distelman MenachemYael LaitmanEitan Friedman OriginalPaper 11 June 2009 Pages: 399 - 402
Cancer genetic predisposition: information needs of patients irrespective of risk level Alison MetcalfeJulie WerrettCollette Clifford OriginalPaper 11 June 2009 Pages: 403 - 412
A high frequent BRCA1 founder mutation identified in the Greenlandic population Theresa Larriba HarboeHans EibergMarie Luise Bisgaard OriginalPaper 07 June 2009 Pages: 413 - 419
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome Gašper BergincMatej BračkoDamjan Glavač OriginalPaper 13 June 2009 Pages: 421 - 429
Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study K. ElmasryA. J. DaviesK. Reynolds OriginalPaper 13 June 2009 Pages: 431 - 439
Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer Gwendolyn P. QuinnSusan T. VadaparampilSue Friedman OriginalPaper 25 June 2009 Pages: 441 - 449
Younger age-at-diagnosis for familial malignant testicular germ cell tumor Phuong L. MaiBingshu E. ChenMark H. Greene OriginalPaper 17 July 2009 Pages: 451 - 456
Attitude towards pre-implantation genetic diagnosis for hereditary cancer Chantal LammensEveline BleikerSenno Verhoef OriginalPaper Open access 30 July 2009 Pages: 457 - 464
Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease Shirin Hasani-RanjbarMahsa M. AmoliBagher Larijani OriginalPaper 01 August 2009 Pages: 465 - 471
Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations Bella KaufmanYael LaitmanEitan Friedman OriginalPaper 17 July 2009 Pages: 473 - 478
Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer Emma EdwardsCatharina YearwoodDiana Eccles BriefCommunication 21 July 2009 Pages: 479 - 482
Are prediction models for Lynch syndrome valid for probands with endometrial cancer? Floor J. BackesHeather HampelDavid E. Cohn OriginalPaper 30 July 2009 Pages: 483 - 487
Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients Lise Lotte ChristensenReetta KariolaTorben F. Ørntoft OriginalPaper 21 August 2009 Pages: 489 - 500
Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for lynch syndrome Israel ZighelboimMatthew A. PowellPaul J. Goodfellow BriefCommunication Open access 12 August 2009 Pages: 501 - 504
Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population Moon-Woo SeongSung Im ChoSung Sup Park OriginalPaper 08 August 2009 Pages: 505 - 508
Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay Hiromu NaruseNoriko IkawaYoichi Furukawa OriginalPaper 15 August 2009 Pages: 509 - 517
Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation D. A. StupartP. A. GoldbergR. Ramesar OriginalPaper 18 August 2009 Pages: 519 - 523
Association of MUTYH and MSH6 germline mutations in colorectal cancer patients María Dolores GiráldezFrancesc BalaguerGastrointestinal Oncology Group of the Spanish Gastroenterological Association OriginalPaper 15 August 2009 Pages: 525 - 531
A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations Cristina Martínez-BouzasElena BeristainMaria Isabel Tejada OriginalPaper 17 September 2009 Pages: 533 - 539
p53 tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li–Fraumeni syndrome and a child with adrenocortical carcinoma Lucja Fiszer-MaliszewskaBernarda KazanowskaThe Regional Blood Transfusion Center OriginalPaper 28 August 2009 Pages: 541 - 546
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome S. GargiuloM. TorriniP. Ghiorzo OriginalPaper 01 September 2009 Pages: 547 - 553
The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer Helgi BirgissonArezo GhanipourBengt Glimelius OriginalPaper 28 August 2009 Pages: 555 - 561
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30 Ophira M. GinsburgMohammad R. AkbariSteven A. Narod OriginalPaper 28 August 2009 Pages: 563 - 567
FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin David E. JoynerSylvia H. TrangR. Lor Randall OriginalPaper 02 September 2009 Pages: 569 - 580
Molecular study of CEPBA in familial hematological malignancies R. El AbedV. BourdonH. Sobol BriefCommunication 03 September 2009 Pages: 581 - 584
